In a 1st, US patient begins gene therapy for sickle cell disease
On Wednesday, Kendric Cromer, a 12-year-old boy from a suburb of Washington, became the first person in the world with sickle cell disease to begin a commercially approved gene therapy that may cure the condition.
No comments:
Post a Comment